ALPS Advisors
MBX icon

ALPS Advisors’s MBX Biosciences MBX Stock Holding History

ALPS Advisors’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.74M Buy
63,800
+15,788
+33% +$988K 0.02% 340
2026
Q2 		$2.65M Buy
48,012
+11,462
+31% +$400K 0.01% 442
2026
Q1 		$1.09M Sell
36,550
-322
-0.9% -$11K 0.01% 574
2025
Q4 		$1.16M Buy
36,872
+20,032
+119% +$486K 0.01% 509
2025
Q3 		$295K Sell
16,840
-1,208
-7% -$16.2K ﹤0.01% 988
2025
Q2 		$206K Sell
18,048
-7,986
-31% -$81.4K ﹤0.01% 1004
2025
Q1 		$192K Sell
26,034
-986
-4% -$10.4K ﹤0.01% 963
2024
Q4 		$498K Buy
+27,020
New +$576K ﹤0.01% 604

Other funds holding MBX

Aaron Wealth Advisors
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Sowell Financial Services
Sowell Financial Services North Little Rock, Arkansas $3.12B AUM 22.73% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
Koa Wealth Management
Koa Wealth Management Encinitas, California $154M AUM 13.16% 1-Year Est. Return

ALPS Advisors's MBX Position: Q3 2026 in Review

ALPS Advisors increased its MBX Biosciences (MBX) stake by 33% in Q3 2026, buying an estimated $988K and bringing the position to 63,800 shares worth $3.74M. The position accounts for 0.02% of the portfolio, ranked #340.

ALPS Advisors first reported a position in MBX in Q4 2024 and has held it in 8 quarters since. 51 funds tracked by Wall St. Rank hold MBX as of Q3 2026.

  • ALPS Advisors held 63,800 shares of MBX Biosciences worth $3.74M as of Q3 2026.
  • ALPS Advisors bought 15,788 MBX Biosciences shares in Q3 2026, an estimated $988K.
  • MBX Biosciences made up 0.02% of ALPS Advisors's portfolio in Q3 2026, its #340 holding.
  • ALPS Advisors first reported a position in MBX Biosciences in Q4 2024 and has held it in 8 quarters since.
  • 51 funds tracked by Wall St. Rank held MBX Biosciences as of Q3 2026.

Based on ALPS Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.